G1 Therapeutics Inc (NASDAQ:GTHX)
| 1.40 BATS BZX Real-Time Price As of 10:06am ET |  -0.02 / -1.41%Today’s Change | 1.17 Today|||52-Week Range 13.85 | -74.22% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 522.4K | 0.00 | 0.00 | 0.00 | |
| Depreciation And Amortization | 42.3K | 67.2K | 89.0K | 175.0K | ||
| Operating Expenses | Gross Income | -- | -67.2K | -89.0K | -175.0K | |
| General Expenses | 15.9M | 30.3M | 60.9M | 89.1M | ||
| Research And Development | 12.7M | 25.2M | 53.9M | 70.7M | ||
| Total Operating Expenses | 15.9M | 30.4M | 61.0M | 89.3M | ||
| Non-Operating Expenses | Operating Income | -15.4M | -30.4M | -61.0M | -89.3M | |
| Extraordinary Charge | -4.9M | -82.2K | -41.0K | 0.00 | ||
| Other Expenses | 17.8K | 182.4K | 888.0K | 4.0M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -20.3M | -30.3M | -60.1M | -85.3M | |
| Preferred Dividend | -1.4M | -4.4M | -4.8M | 0.00 | ||
| Net Income | -20.3M | -30.3M | -60.1M | -85.3M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 61.2M | 28.5M | 32.3M | 33.3M | |
| Shares To Calculate EPS Diluted | 61.2M | 28.5M | 32.3M | 33.3M | ||
| Earnings Per Share | EPS | -$0.35 | -$0.54 | -$2.01 | -$2.56 | |
| EPS Diluted | -$0.35 | -$1.22 | -$2.01 | -$2.56 | ||
